Company profile
Contact details
Millimed Co., Ltd was established on March 3, 2000 with initial capital of 10 million baht (us250,000) by taking over Bayer Laboratories production plant in Samutprakarn and in September 2003 the company took over another production plant from Glaxo Wellcome Vidhyasom in the same district.
In 2002 2003, the company was in the process of submitting its company and product registration to the Ministry of Health. The process took almost 2 years so it effected only small amount of sale that the company could achieve during that time.
In 2003, the company took over production plant from Glaxo Wellcome Vidhyasom, which is one of the modernized company in Thailand, in order to produce high quality products for the Thai market and export to the world market as well.
YearCompanys Turnover
(Mill ...ion US)
20058.50
200611.89
200713.92
At present, the company has registered its products with Ministry of Health in a total of 367 items and still in the process around 200 items. Millimed has a comparative advantage in terms of holding dossier of 367 items compare to other competitors because we could serve the customers with all aspects of products in the pharmaceutical market. Read more
In 2002 2003, the company was in the process of submitting its company and product registration to the Ministry of Health. The process took almost 2 years so it effected only small amount of sale that the company could achieve during that time.
In 2003, the company took over production plant from Glaxo Wellcome Vidhyasom, which is one of the modernized company in Thailand, in order to produce high quality products for the Thai market and export to the world market as well.
YearCompanys Turnover
(Mill ...ion US)
20058.50
200611.89
200713.92
At present, the company has registered its products with Ministry of Health in a total of 367 items and still in the process around 200 items. Millimed has a comparative advantage in terms of holding dossier of 367 items compare to other competitors because we could serve the customers with all aspects of products in the pharmaceutical market. Read more